Dental implants in a patient with Paget disease under bisphosphonate treatment: A case report

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 107, Issue 3, 2009, Pages 387-392

  Torres, Jesús ^a   Tamimi, Faleh ^b   Garcia, Ignacio ^a   Herrero, Alicia ^a   Rivera, Begoña ^a   Sobrino, Jose Andrés ^a   Hernández, Gonzalo ^c  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT; DRUG DERIVATIVE; ETIDRONIC ACID; RISEDRONIC ACID;

ARTICLE; CASE REPORT; DENTURE; EDENTULOUSNESS; FEMALE; HUMAN; MAXILLA; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PAGET BONE DISEASE; TOOTH IMPLANTATION; TOOTH PROSTHESIS;

ADMINISTRATION, ORAL; BONE DENSITY CONSERVATION AGENTS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL PROSTHESIS, IMPLANT-SUPPORTED; DENTURE, PARTIAL, FIXED; ETIDRONIC ACID; FEMALE; HUMANS; JAW, EDENTULOUS, PARTIALLY; MAXILLA; MIDDLE AGED; OSTEITIS DEFORMANS;

EID: 59649114975     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.11.024     Document Type: Article

References (46)

1. Adell R., Eriksson B., Lekholm U., Branemark P.I., and Jemt T. Long-term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral Maxillofac Implants 5 (1990) 347-359
2. Romeo E., Chiapasco M., Ghisolfi M., and Vogel G. Long-term clinical effectiveness of oral implants in the treatment of partial edentulism. Seven-year life table analysis of a prospective study with ITI dental implants system used for single-tooth restorations. Clin Oral Implants Res 13 (2002) 133-143
3. Avivi-Arber L., and Zarb G.A. Clinical effectiveness of implant-supported single-tooth replacement: the Toronto Study. Int J Oral Maxillofac Implants 11 (1996) 311-321
4. Lekholm U., and Zarb G.A. Patient selection and preparation. In: Branemark P.-I., Zarb G.A., and Albrektsson T. (Eds). Tissue-integrated protheses: osteointegration in clinical dentistry (1985), Quintessence, Chicago 199-209
5. Jaffin R.A., and Berman C.L. The excessive loss of Branemark fixtures in type IV bone: a 5-year analysis. J Periodontol 62 (1991) 2-4
6. Piattelli A., Scarano A., Favero L., Iezzi G., Petrone G., and Favero G.A. Clinical and histologic aspects of dental implants removed due to mobility. J Periodontol 74 (2003) 385-390
7. Engquist B., Bergendal T., Kallus T., and Linden U. A retrospective multicenter evaluation of osseointegrated implants supporting overdentures. Int J Oral Maxillofac Implants 3 (1988) 129-134
8. Alsaadi G., Quirynen M., Komárek A., and van Steenberghe D. Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. J Clin Periodontol 7 (2007) 610-617
9. Beikler T., and Flemmig T.F. Implants in the medically compromised patient. Crit Rev Oral Biol Med 14 (2003) 305-316
10. Sugerman P.B., and Barber M.T. Patient selection for endosseous dental implants: oral and systemic considerations. Int J Oral Maxillofac Implants 17 (2002) 191-201
11. Erdogan O., Shafer D.M., Taxel P., and Freilich M.A. A review of the association between osteoporosis and alveolar ridge augmentation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 (2007) 738.e1-738.e13
12. Paget J. On a form of chronic inflammation of bones (osteitis deformans). Clin Orthop Relat Res 49 (1966) 3-16
13. Walsh J.P. Paget's disease of bone. Med J Aust 181 (2004) 262-265
14. Delmas P.D., and Meunier P.J. The management of Paget's disease of bone. N Engl J Med 336 (1997) 558-566
15. Cooper C., Harvey N.C., Dennison E.M., and van Staa T.P. Update on the epidemiology of Paget's disease of bone. J Bone Miner Res 21 Suppl 2 (2006) P3-P8
16. Gardner M.J., Guyer P.B., and Barker D.J.P. Radiological prevalence of Paget's disease of bone in British migrants to Australia. Br Med J 1 (1978) 1655-1657
17. Guyer P.B., and Chamberlain A.T. Paget's disease of bone in two American cities. Br Med J 280 (1982) 985
18. Detheridge F.M., Guyer P.B., and Barker D.J.P. European distribution of Paget's disease of bone. Br Med J 285 (1982) 1005-1008
19. Rebel A., Basle M., Pouplard A., Kouyoumdjian S., Filmon R., and Lepatezour A. Viral antigens in osteoclasts from Paget's disease of bone. Lancet 2 (1980) 344-346
20. Tiegs R.D., Lohse C.M., Wollan P.C., and Melton L.J. Long-term trends in the incidence of Paget's disease of bone. Bone 27 (2000) 423-427
21. Sofaer J.A. Dental extractions in Paget's disease of bone. Int J Oral Surg 13 (1984) 79-84
22. Thomas D.W., and Shepherd J.P. Paget's disease of bone: current concepts in pathogenesis and treatment. J Oral Pathol Med 23 (1994) 12-16
23. Marx R.E., Sawatari Y., Fortin M., and Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 (2005) 1567-1575
24. Brooks J.K., Gilson A.J., Sindler A.J., Ashman S.G., Schwartz K.G., and Nikitakis N.G. Osteonecrosis of the jaws associated with the use of risedronate: report of 2 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (2007) 780-786
25. Jeffcoat M.K. Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants 21 (2006) 349-353
26. Fugazzotto P.A., Lightfoot W.S., Jaffin R., and Kumar A. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol 78 (2007) 1664-1669
27. Hwang D., and Wang H.L. Medical contraindications to implant therapy: part II: relative contraindications. Implant Dent 16 (2007) 13-23
28. Hwang D., and Wang H.L. Medical contraindications to implant therapy: part I: absolute contraindications. Implant Dent 15 (2006) 353-360
29. Scully C., Hobkirk J., and Dios P.D. Dental endosseous implants in the medically compromised patient. J Oral Rehabil 34 (2007) 590-599
30. Meredith N. Assessment of implant stability as a prognostic determinant. Int J Prosthodont 11 (1998) 491-501
31. Wiesenfeld D., Cook R.M., Bennet K.R., and Radden B.G. The correction of mandibular deformity due to Paget's disease of bone. J Oral Maxillofac Surg 43 (1985) 125-129
32. Martinez-Lage J.L., Almeida F., Picón M., Lorenzo F., and Carrillo R. Maxillomalar monoblock removal, reshaping, and reinsertion in Paget's disease: 15-year follow-up. J Oral Maxillofac Surg 63 (2005) 1680-1685
33. Rasmussen J.M., and Hopfensperger M.L. Placement and restoration of dental implants in a patient with Paget's disease in remission: literature review and clinical report. J Prosthodont 17 (2008) 35-40
34. Wheeler T.T., Alberts M.A., Dolan T.A., and McGorray S.P. Dental, visual, auditory and olfactory complications in Paget's disease of bone. J Am Geriatr Soc 43 (1995) 1384-1391
35. Scully C., and Levers B.G. The person behind the eponym: Sir James Paget (1814-1899). J Oral Pathol Med 23 (1994) 375-376
36. Solt D.B. The pathogenesis, oral manifestations, and implications for dentistry of metabolic bone disease. Curr Opin Dent 1 (1991) 783-791
37. Wood J., Bonjean K., Ruetz S., Bellahcene A., Devy L., Foidart J.M., et al. Novel antiangiogenic effects of the biphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302 (2002) 1055-1061
38. Fournier P., Boissier S., and Filleur S. Biphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62 (2002) 6538-6544
39. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115-1117
40. Migliorati C.A. Biphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21 (2003) 4253-4254
41. Ruggiero S.L., Mehrotra B., and Engroff S.L. Osteonecrosis of the jaws associated with the use of biphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527-534
42. American Dental Association Council on Scientific Affairs. Dental management of patients on oral bisphosphonate therapy: expert panel recomendations. J Am Dent Assoc 137 (2006) 1144-1150
43. Hansen T., Kunkel M., Weber A., and Kirkpatrick C.J. Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35 (2006) 155-160
44. Vescovi P., Merigo E., Meleti M., and Manfredi M. Bisphosphonate-associated osteonecrosis (BON) of the jaws: a possible treatment?. J Oral Maxillofac Surg 64 (2006) 1460-1462
45. King A.E., and Umland E.M. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates. Pharmacotherapy 28 (2008) 667-677
46. Migliorati C.A., Siegel M.A., and Elting L.S. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 7 (2006) 508-514